TODAY'S MARKET INTELLIGENCE
Buchang Pharmaceutical subsidiary's clinical trial application accepted
English summary
Buchang Pharmaceutical's controlling subsidiary has its drug clinical trial application accepted, indicating progress in its R&D pipeline, which could positively impact the company in the long run.
The English text is machine translated and may require verification against the Chinese version.
Browse today's intelligence